Your shopping cart is currently empty

PID-9 is a P-glycoprotein inhibitor with activity to reverse multidrug resistance (MDR) with an IC50 of 0.1338 μM, and it exhibits low toxicity. It inhibits the transport function of P-gp without reducing P-gp expression.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | PID-9 is a P-glycoprotein inhibitor with activity to reverse multidrug resistance (MDR) with an IC50 of 0.1338 μM, and it exhibits low toxicity. It inhibits the transport function of P-gp without reducing P-gp expression. |
| In vitro | PID-9 (2.5 μM) enhances intracellular accumulation of doxorubicin (10 μM) in drug-resistant SW620/AD300 cells and promotes doxorubicin-induced apoptosis. |
| Formula | C50H57N5O6 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.